Andrew Gelman

With a new $7.3 million grant from the National Institutes of Health (NIH), a team of lung transplant surgeons and researchers at Washington University School of Medicine in St. Louis is investigating the immunological basis of lung transplant rejection, with the aim of improving the long-term outlook for patients. ​

Broadly suppressing the immune system after lung transplantation inadvertently may encourage organ rejection, according to a new School of Medicine study in mice. Shown, from left, are study co-authors Daniel Kreisel, MD, PhD, Andrew Gelman, PhD, and Alexander Krupnick, MD.